<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30268633</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>10</Month>            <Day>29</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>29</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1769-6917</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>105</Volume>                    <Issue>10</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                    </PubDate>                </JournalIssue>                <Title>Bulletin du cancer</Title>                <ISOAbbreviation>Bull Cancer</ISOAbbreviation>            </Journal>            <ArticleTitle>[The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition].</ArticleTitle>            <Pagination>                <MedlinePgn>907-917</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">S0007-4551(18)30224-8</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bulcan.2018.08.003</ELocationID>            <Abstract>                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Next generation sequencing allows the simultaneous analysis of large panel of genes for families or individuals with a strong suspicion of hereditary breast and/or ovarian cancer (HBOC). Because of lack of guidelines, several panels of genes potentially involved in HBOC were designed, with large disparities not only in their composition but also in medical care offered to mutation carriers. Then, homogenization in practices is needed.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">The French Genetic and Cancer Group (GGC) - Unicancer conducted an exhaustive bibliographic work on 18 genes of interest. Only publications with unbiased risk estimates were retained.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The expertise of each 18 genes was based on clinical utility criteria, i.e. a relative risk of cancer of 4 and more, available medical tools for screening and prevention of mutation carriers, and pre-symptomatic genetic tests for relatives. Finally, 13 genes were selected to be included in a HBOC diagnosis gene panel: BRCA1, BRCA2, PALB2, TP53, CDH1, PTEN, RAD51C, RAD51D, MLH1, MSH2, MSH6, PMS2, EPCAM. The reasons for excluding NBN, RAD51B, CHEK2, STK11, ATM, BARD1, BRIP1 from the HBOC diagnosis panel are presented. Screening, prevention and genetic counselling guidelines were detailed for each of the 18 genes.</AbstractText>                <AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Due to the rapid increase in knowledge, the GGC has planned a yearly update of the bibliography to take into account new findings. Furthermore, genetic-epidemiological studies are being initiated to better estimate the cancer risk associated with genes which are not yet included in the HBOC diagnosis panel.</AbstractText>                <CopyrightInformation>Copyright © 2018 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Moretta</LastName>                    <ForeName>Jessica</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Institut Paoli-Calmettes, oncogénétique clinique, département d'anticipation et de suivi des cancers, 232, boulevard Sainte-Marguerite, 13009 Marseille, France. Electronic address: morettaj@ipc.unicancer.fr.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Berthet</LastName>                    <ForeName>Pascaline</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Centre François-Baclesse, oncogénétique clinique, département de biopathologie, 14000 Caen, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bonadona</LastName>                    <ForeName>Valérie</ForeName>                    <Initials>V</Initials>                    <AffiliationInfo>                        <Affiliation>Centre Léon-Berard, unité clinique d'oncologie génétique, 69008 Lyon, France; Université Lyon 1, CNRS, LBBE UMR 5558, 69622 Villeurbanne, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Caron</LastName>                    <ForeName>Olivier</ForeName>                    <Initials>O</Initials>                    <AffiliationInfo>                        <Affiliation>Gustave-Roussy hôpital universitaire, département de médecine, 94800 Villejuif, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Cohen-Haguenauer</LastName>                    <ForeName>Odile</ForeName>                    <Initials>O</Initials>                    <AffiliationInfo>                        <Affiliation>GH Saint-Louis-Lariboisière-Fernand-Widal, oncogénétique, 75010 Paris, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Colas</LastName>                    <ForeName>Chrystelle</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Institut Curie, oncogénétique, 75005 Paris, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Corsini</LastName>                    <ForeName>Carole</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>CHRU de Montpellier, hôpital Arnaud de Villeneuve, service d'oncogénétique, 34090 Montpellier, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Cusin</LastName>                    <ForeName>Véronica</ForeName>                    <Initials>V</Initials>                    <AffiliationInfo>                        <Affiliation>Hôpital Pitié-Salpêtrière-Charles-Foix, service de génétique, 75013 Paris, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>De Pauw</LastName>                    <ForeName>Antoine</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Institut Curie, oncogénétique, 75005 Paris, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Delnatte</LastName>                    <ForeName>Capucine</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>ICO-Centre René-Gauducheau, unité d'oncogénétique, 44800 Nantes, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Dussart</LastName>                    <ForeName>Sophie</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Centre Léon-Berard, unité clinique d'oncologie génétique, 69008 Lyon, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Jamain</LastName>                    <ForeName>Christophe</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Unicancer, 75654 Paris France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Longy</LastName>                    <ForeName>Michel</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Institut Bergonié, oncogénétique, Inserm U 1218, 33000 Bordeaux, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Luporsi</LastName>                    <ForeName>Elisabeth</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>CHR de Metz Thionville, oncogénétique, 57100 Metz, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Maugard</LastName>                    <ForeName>Christine</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>CHU de Strasbourg, oncogénétique clinique, oncogénétique moléculaire, évaluation familiale et suivi, laboratoire d'oncobiologie, 67000 Strasbourg, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Nguyen</LastName>                    <ForeName>Tan Dat</ForeName>                    <Initials>TD</Initials>                    <AffiliationInfo>                        <Affiliation>Institut Jean-Godinot, oncogénétique, 51100 Reims, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pujol</LastName>                    <ForeName>Pascal</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>CHRU de Montpellier, hôpital Arnaud de Villeneuve, service d'oncogénétique, 34090 Montpellier, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Vaur</LastName>                    <ForeName>Dominique</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Centre François-Baclesse, laboratoire de biologie et de génétique du cancer, 14000 Caen, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Andrieu</LastName>                    <ForeName>Nadine</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Inserm, U900, Institut Curie, PSL Research University, Mines ParisTech, 75005 Paris, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lasset</LastName>                    <ForeName>Christine</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Université Lyon 1, CNRS, LBBE UMR 5558, 69622 Villeurbanne, France; Centre Léon Bérard, département de santé publique, unité de prévention et épidémiologie génétique, 69008 Lyon, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Noguès</LastName>                    <ForeName>Catherine</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Institut Paoli-Calmettes, oncogénétique clinique, département d'anticipation et de suivi des cancers, 232, boulevard Sainte-Marguerite, 13009 Marseille, France; Aix-Marseille université, Inserm, IRD, SESSTIM, 13000 Marseille, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <CollectiveName>Groupe Génétique et Cancer d’Unicancer</CollectiveName>                </Author>            </AuthorList>            <Language>fre</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D017065">Practice Guideline</PublicationType>            </PublicationTypeList>            <VernacularTitle>Recommandations françaises du Groupe Génétique et Cancer pour l’analyse en panel de gènes dans les prédispositions héréditaires au cancer du sein ou de l’ovaire.</VernacularTitle>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>27</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>France</Country>            <MedlineTA>Bull Cancer</MedlineTA>            <NlmUniqueID>0072416</NlmUniqueID>            <ISSNLinking>0007-4551</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="C513384">CDH1 protein, human</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D015820">Cadherins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000071858">Epithelial Cell Adhesion Molecule</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000076164">Fanconi Anemia Complementation Group N Protein</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="C094443">G-T mismatch-binding protein</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D005819">Genetic Markers</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="C501486">MLH1 protein, human</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="C512790">PALB2 protein, human</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="C112629">RAD51D protein, human</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 3.1.3.67</RegistryNumber>                <NameOfSubstance UI="D051059">PTEN Phosphohydrolase</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 3.1.3.67</RegistryNumber>                <NameOfSubstance UI="C494929">PTEN protein, human</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 3.6.1.-</RegistryNumber>                <NameOfSubstance UI="C094934">PMS2 protein, human</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 3.6.1.3</RegistryNumber>                <NameOfSubstance UI="C497172">MSH2 protein, human</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 3.6.1.3</RegistryNumber>                <NameOfSubstance UI="D000070976">Mismatch Repair Endonuclease PMS2</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 3.6.1.3</RegistryNumber>                <NameOfSubstance UI="D000070957">MutL Protein Homolog 1</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 3.6.1.3</RegistryNumber>                <NameOfSubstance UI="D051718">MutS Homolog 2 Protein</NameOfSubstance>            </Chemical>        </ChemicalList>        <SupplMeshList>            <SupplMeshName Type="Disease" UI="C562840">Breast Cancer, Familial</SupplMeshName>        </SupplMeshList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D015820" MajorTopicYN="N">Cadherins</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000071858" MajorTopicYN="N">Epithelial Cell Adhesion Molecule</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000076164" MajorTopicYN="N">Fanconi Anemia Complementation Group N Protein</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005602" MajorTopicYN="N">France</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D019398" MajorTopicYN="N">Genes, BRCA1</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D024522" MajorTopicYN="N">Genes, BRCA2</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D016158" MajorTopicYN="N">Genes, p53</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005819" MajorTopicYN="N">Genetic Markers</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000070976" MajorTopicYN="N">Mismatch Repair Endonuclease PMS2</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000070957" MajorTopicYN="N">MutL Protein Homolog 1</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D051718" MajorTopicYN="N">MutS Homolog 2 Protein</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D010051" MajorTopicYN="N">Ovarian Neoplasms</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D051059" MajorTopicYN="N">PTEN Phosphohydrolase</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">Cancer de l’ovaire</Keyword>            <Keyword MajorTopicYN="N">Cancer du sein</Keyword>            <Keyword MajorTopicYN="N">Cancer genetics</Keyword>            <Keyword MajorTopicYN="N">Cancers héréditaires</Keyword>            <Keyword MajorTopicYN="N">Conseil génétique</Keyword>            <Keyword MajorTopicYN="N">Genetic counseling</Keyword>            <Keyword MajorTopicYN="N">Guidelines</Keyword>            <Keyword MajorTopicYN="N">Mutigene panels</Keyword>            <Keyword MajorTopicYN="N">Ovarian cancer</Keyword>            <Keyword MajorTopicYN="N">Panel de gènes</Keyword>            <Keyword MajorTopicYN="N">Recommandations</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>07</Month>                <Day>13</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>08</Month>                <Day>03</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>08</Month>                <Day>06</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>30</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30268633</ArticleId>            <ArticleId IdType="pii">S0007-4551(18)30224-8</ArticleId>            <ArticleId IdType="doi">10.1016/j.bulcan.2018.08.003</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>